Inhibitory Antibodies
抑制性抗体(Inhibitory Antibodies,常被称为中和抗体或阻断抗体)是一种能够特异性结合目标分子(如受体、酶或细胞因子),并直接抑制或阻断其正常生物学功能的特异性抗体。
| 货号 | 产品 | 反应 | 应用 | 偶联 | 引用 |
|---|---|---|---|---|---|
| BF6200 | Adakitug | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6201 | Landogrozumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6202 | Brontictuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6203 | Rinucumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6204 | Romosozumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6205 | Linavonkibart | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6206 | Bintrafusp alfa | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6207 | Timolumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6208 | STX-100 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6209 | Anti-SLC44A4 Ab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6210 | Cusatuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6211 | Selicrelumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6212 | Lintuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6213 | Crenezumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6214 | MEDI-3617 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6215 | Zansecimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6216 | Adebrelimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6217 | NI-0701 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6218 | Anti-IL-13 Ab (CNTO 607) | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6219 | Ripertamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6220 | Veltuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6221 | Cudarolimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6222 | Mezagitamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6223 | Letaplimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6224 | PF-03732010 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6225 | Litifilimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6226 | Enoticumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6227 | Nurulimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6228 | NI-0801 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6229 | Foralumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6230 | Frovocimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6231 | Gancotamab Ab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6232 | Gatipotuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6233 | Giloralimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6234 | MEDI-578 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6235 | Tifcemalimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6236 | Margetuximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6237 | Lumretuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6238 | Abelacimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6239 | Pelgifatamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6240 | Letolizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6241 | Lilotomab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6242 | Lonigutamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6243 | Losatuxizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6244 | Modotuximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6245 | Nofazinlimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6246 | Melrilimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6247 | Brazikumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6248 | Ziltivekimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6249 | Olinvacimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |